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MESH TERMS 33 
Chronic rhinosinusitis, health inequalities, quality of life, respiratory disease, socioeconomic 34 
factors 35 
Thus study is reported according to the STROBE statement for observational studies. 36 
37 
  
ABSTRACT 38 
Background 39 
Chronic rhinosinusitis (CRS) is a common and debilitating disorder. Little is known about the 40 
epidemiology of this disease. The aims of the study were to identify differences in socio-41 
economic variables and quality of life between patients with chronic rhinosinusitis and 42 
healthy controls, to identify any significant associations between CRS and other medical co-43 
morbidities, psychiatric disease or environmental exposure and to explore the experience of 44 
CRS from the perspective of CRS sufferers. 45 
Methods 46 
Participants were recruited from ENT clinics from 30 centres across the UK. They completed 47 
a study-specific questionnaire considering environmental, medical and socio-economic 48 
factors, and SF-36 and SNOT-22 scores. All participants with CRS were diagnosed by a clinician 49 
and categorised as having CRS (with polyposis, without polyposis or allergic fungal 50 
rhinosinusitis (AFRS)). Controls included family and friends of those attending ENT outpatient 51 
clinics and hospital staff who had no diagnosis of nose or sinus problems and had not been 52 
admitted to hospital in the previous 12 months. 53 
Results 54 
A total of 1470 study participants (1249 patients and 221 controls) were included in the final 55 
analysis. Highly significant differences were seen in generic and disease-specific quality of life 56 
scores between CRS sufferers and controls; mean  SNOT-22 score 45.0 for CRS compared with 57 
12.1 amongst controls (p<0.001). There were no clear differences in socioeconomic variables 58 
including, social class, index of multiple deprivation and educational attainment between 59 
cases and controls. Common comorbidities with a clear association included respiratory and 60 
psychiatric disorders (p ≤ .0.001), with a higher frequency of reported upper respiratory tract 61 
infections. 62 
 63 
Conclusions 64 
CRS is associated with significant impairment in quality of life and with associated medical co-65 
morbidities. In contrast to other common ENT disorders, no socioeconomic differences in CRS 66 
were found between patients and controls in this study. 67 
68 
  
INTRODUCTION  69 
Background and rationale 70 
Chronic rhinosinusitis (CRS) affects a significant proportion of the population; a recent 71 
European study found a prevalence of 11%(1).  Despite this, the epidemiology of CRS and in 72 
particular its association with socioeconomic variables has not been extensively explored. The 73 
European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS 2012) has stated under the 74 
heading ‘Research Needs’ that studies are required to  consider ‘the prevalence of and 75 
predisposing factors for CRSsNPs and CRSwNPs’ and to ‘investigate the impact of 76 
psychological problems such as depression, stress exposure and anxiety on subjective 77 
severity’(2). A previous study of 158 patients has suggested significant morbidity in CRS with 78 
quality of life scores worse than amongst those with other chronic diseases such as lower 79 
back pain(3). This significant effect on an individual’s functioning and productivity, since CRS 80 
primarily affects those aged 40-60 years, has an impact upon workforce productivity. CRS has 81 
been identified as one of the top ten most costly diseases for US employers (4).  Despite its 82 
high prevalence and impact, the pathophysiology and hence optimal treatment for CRS are 83 
not well understood, but it is thought to be a spectrum of diseases with different underlying 84 
aetiologies and pathological features. Infection (viral, bacterial and fungal) and underlying 85 
genetic tendencies may all be contributory factors. CRS is currently subdivided into two main 86 
types – CRS with and without nasal polyps (CRSwNPs and CRSsNPs respectively), as 87 
exemplified by EPOS 2012(2) to reflect coarsely differing gross pathophysiology (eosinophilic 88 
or neutrophilic) but allergic fungal rhinosinusitis (AFRS) is an increasingly recognised distinct 89 
subtype of CRSwNPs. 90 
Deprivation is known to be associated with increasing morbidity and mortality, and is 91 
therefore important to consider in understanding the epidemiology of any disease, since it is 92 
a potentially reversible determinant of health (5). Many reasons for this relationship have been 93 
explored. Poor nutrition leads to poor mental and physical development. Cold or damp 94 
housing is associated with increased risk of respiratory diseases, and overcrowded housing is 95 
associated with infectious diseases (6). Behavioural differences which may be related to lack 96 
of resources or poor education also contribute to socioeconomic variation in health, with 97 
smoking being the most common example. Reduced access to health care, genetic factors 98 
and adverse social conditions also contribute (7). Within otorhinolaryngology it is known that 99 
  
one of the most common risk factors for otitis media is socioeconomic status (8), with more 100 
deprived children more likely to suffer adversely with the condition. There is controversy as 101 
to the role of deprivation in other upper respiratory problems; the direction of association 102 
between asthma and socioeconomic status varies widely between studies (9) (10). 103 
By developing our understanding about the socio-economic and co-morbidity factors that 104 
may influence CRS, specific co-morbid associations and high-risk population groups might be 105 
identified. This information could enable health practitioners, including ENT specialists and 106 
General Practitioners, to better tailor management to individual patients’ needs. 107 
Epidemiological studies outwith Europe have shown varying prevalence rates.  In Canada, the 108 
prevalence of CRS, defined as an confirmatory answer to the question, ‘Has the patient had 109 
sinusitis diagnosed by a health professional lasting for more than 6 months?’ ranged from 110 
3.4% in male to 5.7% in female subjects (11). In Korea, the overall prevalence of CRS, defined 111 
as the presence of at least 3 nasal symptoms persisting for more than 3 months, together 112 
with an endoscopic finding of nasal polyps and/or mucopurulent discharge within the middle 113 
meatus, was 1.01% (12). A comparative study between the north of Scotland and the Caribbean 114 
found that in ENT clinics across both countries, there was a similar prevalence of CRS (9.6% 115 
and 9.3% respectively (13).  116 
Objectives 117 
To date no large scale study into the epidemiology of CRS has been undertaken in the UK and 118 
the Chronic Rhinosinusitis Epidemiology Study (CRES) meets this need. The primary aim of the 119 
study was to identify differences in socio-economic variables and quality of life between 120 
patients with chronic rhinosinusitis and healthy controls. Secondary aims were to identify any 121 
significant associations between CRS and other medical co-morbidities, psychiatric disease or 122 
environmental exposure and to explore the experience of CRS from the perspective of CRS 123 
sufferers. 124 
   125 
126 
  
MATERIALS AND METHODS 127 
Study Design and Setting 128 
CRES was approved by the Oxford C Research Ethics Committee, sponsored by the University 129 
of East Anglia (UEA) and funded by the Anthony Long and Bernice Bibby Trusts. The study was 130 
conducted as a prospective case-control questionnaire study. Following a pilot study of the 131 
questionnaire in 2006, the study commenced recruitment in ENT departments of the East 132 
Anglia region (East of England Deanery) of the UK in 2007. Following elevation to the National 133 
Institute of Health Research Clinical Research Network Portfolio in 2012, a total of 30 sites 134 
from around the UK (including the devolved nations of Wales and Scotland) joined the study 135 
which ran between 2007 and 2013. The study specific questionnaire was anonymous and 136 
therefore consent was implied through participation. Participant information leaflets were 137 
provided.  Questionnaires were completed on one occasion only either before leaving the 138 
clinic or taken home and returned by post in Freepost envelopes. A qualitative arm of the 139 
study was undertaken in 2012. This is published elsewhere (14, 15). 140 
Participants 141 
The diagnosis of CRS was confirmed by an Otorhinolaryngologist. CRS patients presenting to 142 
secondary care ENT outpatient clinics were invited to participate in the study, regardless of 143 
symptom or disease severity or previous treatment, provided they conformed to the 144 
following criteria: 145 
Inclusion criteria: 146 
CRS with or without polyps as defined by the criteria laid out in EPOS 2012(2). Symptoms must 147 
be present for at least 12 weeks and include: 148 
 nasal blockage/obstruction/congestion and/or nasal discharge (anterior/posterior 149 
nasal drip) 150 
 and either facial pain/pressure and/or reduction or loss of smell 151 
and additionally: 152 
 endoscopic signs of: polyps and/or mucopurulent discharge primarily from middle 153 
meatus and/or; oedema/mucosal obstruction primarily in middle meatus 154 
 and/or CT changes: mucosal changes within the ostiomeatal complex and/or sinuses 155 
  
Any patients with nasal polyps placed in the AFRS category met the Bent and Kuhn criteria (16) 156 
or the St Paul’s Sinus Centre modification of this (17).  157 
Patients and controls included were at least 18 years of age. 158 
Exclusion criteria: 159 
 Patients unable to comprehend written English. 160 
For the control group: 161 
 patients with active sinonasal disease - e.g. acute or chronic forms of 162 
rhinitis/rhinosinusitis (as determined by patient history or SNOT-22 score of 10 or more 163 
 no medical co-morbidity (no chronic medical conditions being actively treated) 164 
 hospitalisation within the last 12 months 165 
Controls included family and friends of those attending ENT outpatient clinics and hospital 166 
staff. 167 
Variables and data sources 168 
The study questionnaire was designed with the input of the East of England Research Design 169 
Service and included study specific questions relating to socio-economic, environmental and 170 
medical co-morbid variables as well as the validated Short Form 36 Quality of Life (QoL) 171 
measure (SF-36) (18) measure and the Sino-Nasal Outcome Test questionnaire (SNOT-22)(19).  172 
Socioeconomic variables: 173 
Respondents were asked to enter data for occupation, highest academic qualification, 174 
rural/urban location, duration of residency, proximity to crops, postcode, annual income, 175 
ethnicity and household occupancy. Social class based on the National Statistics Socio-176 
economic Classification (NS-SEC) (20) and the Index of Multiple Deprivation (21) were calculated 177 
and used to assess socio-economic differences. Participants were also asked about tobacco 178 
and alcohol consumption. 179 
Medical Co-morbidities: 180 
Data requested under this category included information on psychiatric disorders, frequency 181 
of common respiratory illnesses, past medical and surgical history, drug history, known and 182 
suspected allergies and sensitivities to aspirin and foods high in salicylate content. 183 
 184 
 185 
  
Sample size calculation 186 
The purpose of the study was to look for common associations between CRS, and primarily 187 
social class (as determined by occupation, highest qualification and household income), and 188 
CRS and housing status (as determined by occupancy of household in conjunction with social 189 
class). These two factors have been used to determine the size of the study sample required. 190 
For socio−economic scores, the standard approach is to compare the proportion of subjects 191 
in the lower social classes to everyone else. In order for the study to have 80% power to detect 192 
a difference of 10% in "low social class" between controls and CRS patients, assuming a 30% 193 
rate in the CRS patients, with approximately 5 CRS patients to 1 control patient, 965 CRS 194 
patients and 193 controls were required.  195 
   For the purposes of assessing QoL, assuming that a change in QoL of 10  units on SF-36 can 196 
be shown (standard deviation of 20), then to have 80% power to detect this difference (at the 197 
5% level of significance), 38 controls and 190 cases would be needed. This would need to be 198 
increased by 20% to allow for the non−normality of QoL and the study would need 46 controls 199 
and 228 cases.  200 
 201 
RESULTS 202 
Participants 203 
A total of 1470 participants with an age range of 17-102 years were recruited. Following 204 
adoption on to the NIHR portfolio, recruitment rates improved to a peak of 120 subjects per 205 
month. After adoption, the overall recruitment was 66% of those invited to participate. 206 
Participants who were recruited prior to adoption onto the portfolio make up the additional 207 
participants. Information on recruitment rates prior to adoption was not collected and there 208 
is no information on reasons for non-participation. A total of 1535 questionnaires were 209 
returned, reduced to 1470 eligible after checking for duplicates and missing information. See 210 
figure 1 for participant flow. 211 
Descriptive and outcome data 212 
The 1470 participants included 709 males and 606 females (155 undeclared); 44% had 213 
CRSsNPs and 56% had CRSwNPs or AFRS. As demonstrated in figure 2, the geographic distribution 214 
of study participants includes a wide range of rural and urban areas of the country and in 3 out of the 215 
4 devolved nations. Table 1 shows detailed demographic information for each of the included 216 
  
subgroups. The full amount of data available was used for each relevant analysis; for example, 217 
if SNOT-22 was completed but not SF-36, participants were included in SNOT-22 analysis but 218 
not SF-36. Similarly, for all socioeconomic factors all participants who completed the relevant 219 
question were included in that particular analysis, to maximize use of the available data. 220 
Main results 221 
Socio-economic outcomes 222 
Social class is an individual-level assessment based on self-reported occupation: 1350 223 
respondents (91.8%) provided this information.  Due to the small number of individuals in 224 
some categories, classes 1.1 and 1.2 were combined, 4 and 5 were combined, and 7 and 8 225 
were combined to assess differences. There was a significant association between social class 226 
and CRS status (p=0.002); however when adjusted for age and sex the difference was no 227 
longer statistical significant (p=0.0684) and there was no specific direction of association. 228 
The index of multiple deprivation (IMD) was also calculated as a measure of socioeconomic 229 
status (21). This is an area-based deprivation measure based on postcode. IMD scores for each 230 
postcode are based on government statistics measuring relative levels of deprivation in small 231 
areas of England called Lower Layer Super Output Areas (LSOAs). Domains include income, 232 
employment, health and disability, education, skills and training, barriers to housing and 233 
services, living environment and crime. Most of the indicators used in these statistics are from 234 
2008.  There were no significant differences between those with CRS and controls (p=0.115); 235 
nor did any appear after adjusting for age and sex (mean difference -1.36, 95% CI: -3.00 to 236 
0.29, p=0.107). 237 
The number of occupants in the household of the participant was also considered; households 238 
of controls tended to have more occupants than households of those with CRS (p=0.003), 239 
however this was not significant after adjusting for age and sex (p=0.275). Household income 240 
(according to the participant) was intended to be used as a further socioeconomic measure 241 
but only two thirds of respondents provided information although no significant differences 242 
were found. Mean income was £41,118.63 for controls and £42,800.02 for those with CRS. 243 
This highest educational qualification achieved by the participant showed no significant 244 
differences between controls and those with CRS (p=0.599). 245 
  
Quality of Life 246 
Quality of life was measured using the SF-36 and SNOT-22. There was a statistically significant 247 
association between SNOT-22 and social class but only a weak correlation was detected 248 
(Spearman rho = 0.0935, p=0.001). There was no correlation between SNOT-22 score and 249 
IMD, number of household occupants or educational attainment. There were statistically 250 
significant associations between three socioeconomic variables and SF-36 but all correlations 251 
were weak. Results are shown in table 2. There were significant differences in mean scores 252 
between controls and those with CRS for both the SF-36 and SNOT-22, before and after 253 
adjustment for age and gender differences. Controls had better scores for both scales as 254 
illustrated in table 3. A further detailed analysis of the SNOT-22 subscales and differences 255 
between CRS subtypes will be reported separately. 256 
Co-morbidities 257 
Several co-morbidities were higher amongst those with CRS than controls, including 258 
psychiatric problems (p=0.001) and respiratory. 259 
CRS and Mood disturbances 260 
Chi-squared test showed significant differences between participant subgroups for both 261 
depression p=0.03 and anxiety p=0.04 and between mental health domain scores on SF-36 262 
(p=0.05). 263 
Allergies 264 
Those with CRS were more likely to report respiratory tract sensitivity to aspirin (p= 0.003), 265 
wine (p<0.001), fruits (0.034) and nuts (0.026), but not to spicy food, drinks or vegetables. 266 
Further analysis is required for the free text answers regarding inhalant allergies and will be 267 
reported elsewhere. 268 
Respiratory 269 
Asthma had a strong association with CRS (<0.001) with those in the AFRS subgroup most 270 
frequently affected. Those with CRS were more likely to report suffering from upper 271 
respiratory tract infections (URTIs) ‘often’ OR=7.39 (95% Confidence interval [CI]: 3.31-16.51) 272 
or ‘frequently’ 30.25 (95% CI 9.77, 93.63). 273 
Burden of surgery 274 
Amongst all CRS patients, 45% had undergone some form of sinonasal surgery previously 275 
(defined as one or more of polypectomy, endoscopic sinus surgery (ESS), septoplasty, 276 
  
turbinate surgery, rhinoplasty) including 325 (26%) who had received at least one nasal 277 
polypectomy and 169 (14%) who had undergone at least one instance of ESS (separately or 278 
concurrently). The mean number of previous surgeries per patient in those had undergone 279 
multiple procedures was 3.3 (range 2–30) and a mean duration of time of 10 years since the 280 
last procedure. A detailed analysis of the surgical data is reported elsewhere (22). 281 
Lifestyle and Environmental Exposure 282 
There were no significant differences in smoking or alcohol consumption between controls and those 283 
with CRS. Nor were there significant differences in proportions of those living near crops 284 
between those with CRS and controls. Data on air pollution for all recruitment sites is 285 
currently being sought and will be reported separately. 286 
 287 
DISCUSSION 288 
 289 
Key Results 290 
Sufficient data on socioeconomic status were collected to enable the primary objectives to 291 
be determined. There were no significant differences in socio-economic variables as 292 
measured by social class, IMD or household occupancy between those with and without CRS. 293 
There have been few previous studies investigating the association between CRS and 294 
different measures of socioeconomic status, particularly in the UK. A similar sized 295 
epidemiological study of residents of Sao Paulo also found no statistically significant 296 
differences in CRS prevalence according to number of household residents, educational 297 
achievement or income of head of household, but did find a significant association between 298 
presence of CRS and belonging to a low-income group (23), although it is noted that social 299 
structure in Sao Paulo is different to the UK. Another study of 127 patients found that lower 300 
family income was related to worse self-reported sinus disease (although there was no 301 
difference in objective sinus disease based on Lund-Mackay score) (24). A study considering 302 
markers of disease severity amongst 93 patients with AFRS in North Carolina, found that bone 303 
erosion and orbitocranial involvement were associated with lower income, rural counties, 304 
poor housing quality, and less health care access (25). Some studies have found that 305 
comparable chronic diseases such as asthma have a strong association between poverty and 306 
  
disease severity (10) but this is controversial(9).  Our study found no differences in education 307 
attainment between cases and controls.  308 
There were weak but statistically significant associations between SNOT-22 score and social 309 
class, and SF-36 score and social class, household occupancy and educational attainment. 310 
Although there is sparse literature investigating such associations amongst those with CRS, 311 
Kilty et al found that those with a lower educational level scored more highly on a sinus 312 
symptom score (24).  313 
Highly significant differences were seen in generic and disease-specific QoL scores between 314 
cases and controls, with cases having less favourable scores on both SF-36 and SNOT-22, 315 
emphasising that CRS patients have a significant impairment of their QoL. This is supported 316 
by several previous studies(26). Potential explanations for the association between 317 
socioeconomic variables and disease severity are likely to be multi-factorial, reflecting the 318 
wide range of influencing aetiological factors in CRS as well as individuals’ perceptions of 319 
symptoms. Several co-morbidities were significantly more likely to be found amongst those 320 
with CRS than controls, including psychiatric problems including mood disturbances and 321 
asthma. Studies considering the biopathophysiological mechanisms which could be involved 322 
in the association between socioeconomic status and the development of asthma have 323 
proposed family stress and endotoxin exposure in low-income households as a factor in 324 
development and experience of symptoms (10). For example, caregiver stress in early life has 325 
been associated with increased levels of TNF-a in infants, which is known to be a pro-326 
inflammatory cytokine in asthma (27). 327 
The proportion of those reporting allergies including aspirin, wine, fruits and nuts was higher 328 
amongst cases and controls. This is supported by several previous studies (28). 329 
There were no significant differences in smoking habits or alcohol intake between cases and 330 
controls. Existing literature varies as to the nature of any association with CRS. Despite being 331 
known to reduce mucociliary clearance time, the association between smoking and CRS varies 332 
between studies (28, 29).  A large epidemiological study of over 73,000 Canadians found no 333 
association between self-reported smoking and CRS; our study supports this finding (11). 334 
Similarly no association between alcohol intake and CRS was found (11). Smoking is associated 335 
with poorer postoperative outcomes(30). 336 
  
Strengths and Limitations 337 
This study includes a varied population from across the United Kingdom. It is the largest study 338 
of CRS in the UK to date. Adoption onto the NIHR portfolio facilitated recruitment and many 339 
sites had excellent participation rates. Participants were recruited regardless of previous and 340 
subsequent management so there was no bias towards surgical or medical treatment. There 341 
should be no difference or bias regarding reporting of socioeconomic factors between 342 
controls and those with CRS. 343 
   The study design had some limitations; it was a self-reported study which predisposes to 344 
recall bias. Only those in secondary or tertiary care were included, although many of those 345 
with CRS are exclusively treated in primary care. There were large amounts of missing data 346 
for some socioeconomic parameters. If the study was redesigned, controls may have been 347 
recruited from a wider pool than just from within hospital staff or from amongst non-CRS ENT 348 
patients/relatives, to increase recruitment particularly amongst males. An online version of 349 
the questionnaire would have also produced a less labour-intensive data processing period at 350 
the end of the study. 351 
   The study did not intend and cannot provide information about prevalence of CRS in the 352 
general population. 353 
Generalisability 354 
Given the scope of the study incorporating a mixture of different sized academic, tertiary and 355 
secondary care sites with participants from a range of urban and rural locations around the 356 
UK, we believe the study findings are applicable to the wider population of CRS sufferers 357 
presenting to ENT departments. However, given a larger burden of CRS patients is managed 358 
in a primary care setting, the results may not necessarily apply to the whole of the CRS 359 
affected population. 360 
 361 
CONCLUSION 362 
Our study is the first study to assess socioeconomic influences in CRS in the UK and found no 363 
socioeconomic differences between those with CRS and controls. This finding is significant in 364 
furthering our understanding of the epidemiology of CRS. We identified significant differences 365 
in health-related QoL reflecting the substantial negative effect of CRS. This increased 366 
  
morbidity leads to the increased health care utilisation by patients with CRS, for both nasal 367 
and non-nasal symptoms, and within both primary and secondary care. Additionally those 368 
with CRS were found to have higher respiratory and psychological co-morbidities. The disease 369 
burden associated with CRS needs to be considered in both individual patients’ management 370 
and when undertaking clinical and epidemiological research into CRS, but also in the context 371 
of planning appropriate use of healthcare resources for this common condition. 372 
 373 
 374 
 375 
 376 
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